Orgenon Likely Acquired by Indian Pharmaceutical Firm
The pharmaceutical company Orgenon is likely to be acquired by the Indian firm Sassan Pharmaceutical. The deal is valued at nearly 12 billion dollars, making it one of the largest foreign acquisitions. This information was reported by Omroep Brabant.
Topics
Developing
- 907d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 907d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 907d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 907d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Omroep Brabant
“Het farmaciëutische bedrijf Orgenon wordt waarschijnlijk overgenomen door het India Sassan Pharmaceutical. Dat is bijna 12 miljard dollar meegemoeid. Daarmee is het een van de grootste buitenlandsel.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade